LG37675-2Oxycodone+Oxymorphone| ANYProp| ANYTm| ANYSys| ANYMethActive
Basic Attributes
- Version First Released
- Pending promotion to Production status
- Parent Group
-
LG80-4 Drug/ToxPotentialForAbuse<SAME:Comp><ROLLUP:Prop|
Tm| Sys| Meth> - Group Category
- Drugs of abuse
LOINC FHIR® API Example - ValueSet Request Get Info
https://fhir.loinc.org/ValueSet/?url=http://loinc.org/vs/LG37675-2
LOINC Terms in this Group
58430-0 | oxyCODONE+oxyMORphone [Presence] in Urine by Screen method |
61197-0 | oxyCODONE+oxyMORphone [Presence] in Urine by Confirmatory method |
71430-3 | oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Screen method |
74658-6 | oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method |
77731-8 | oxyCODONE+oxyMORphone [Interpretation] in Serum, Plasma or Blood Qualitative by Confirmatory method |
77732-6 | oxyCODONE+oxyMORphone [Presence] in Serum, Plasma or Blood by Screen method |
91032-3 | oxyCODONE+oxyMORphone [Presence] in Meconium by Screen method |
91044-8 | oxyCODONE+oxyMORphone [Presence] in Body fluid by Screen method |
91053-9 | oxyCODONE+oxyMORphone [Presence] in Tissue by Screen method |
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright